NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.
Rubio-Gayarre A, Vinyoles M, Tejedor JR, Guerrero-Murillo M, Fernandez-Fuentes N, Caracuel-Peramos R, Plaza-Calonge MC, Martinez-Moreno A, Roca-Ho H, Petazzi P, Pañella-Alférez A, Meseguer-Giron A, Vrenken KS, Fraga MF, Leoz Allegretti P, Palacio-Garcia C, Velasco P, Fuster JL Sr, Stam RW, Rodríguez-Manzaneque JC, Bustelo XR, Robles-Valero J, Menendez P, Bueno C, Lopez-Millan B.
Rubio-Gayarre A, et al. Among authors: bustelo xr.
Blood. 2026 Jun 23:blood.2025031693. doi: 10.1182/blood.2025031693. Online ahead of print.
Blood. 2026.
PMID: 42345361